Takara Bio Inc. (FRA:TF2)

Germany flag Germany · Delayed Price · Currency is EUR
4.140
-0.020 (-0.48%)
Last updated: Dec 5, 2025, 8:04 AM CET
-32.13%
Market Cap 524.15M
Revenue (ttm) 253.84M
Net Income (ttm) -36.76M
Shares Out n/a
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend 0.10 (2.52%)
Ex-Dividend Date Mar 28, 2025
Volume n/a
Average Volume n/a
Open 4.140
Previous Close 4.160
Day's Range 4.140 - 4.140
52-Week Range 4.080 - 6.550
Beta n/a
RSI 36.41
Earnings Date Feb 12, 2026

About Takara Bio

Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and test... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2002
Employees 1,779
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TF2
Full Company Profile

Financial Performance

In 2024, Takara Bio's revenue was 45.04 billion, an increase of 3.53% compared to the previous year's 43.51 billion. Earnings were 1.04 billion, a decrease of -29.66%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.